Since the discovery of the association between AMD and variants in CFH, the systematic study of other genes regulating or involved in the alternative pathway of complement activation has been productive (e.g., the study of CFB/C2, C3 [7-11]). This evidence concerns the gene C3 and age-related macular degeneration.